Inventor · disambiguated record
Bo Chen
Also filed as: CHEN BO · Chen bo-rong
9 granted patents·3 pending applications·63 citations·filing 2008–2024
88Inventor score
Top patents by PatentIndex Score
12 records- 0196US11130816B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2019·Granted Sep 28, 2021·6 cites·20 claims
- 0295US12110338B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2021·Granted Oct 8, 2024·2 cites·29 claims
- 0395US11807690B2Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2019·Granted Nov 7, 2023·4 cites·17 claims
- 0494US10494439B2Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2017·Granted Dec 3, 2019·9 cites·19 claims
- 0594US9701753B2Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2014·Granted Jul 11, 2017·16 cites·25 claims
- 0694US9580511B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2014·Granted Feb 28, 2017·17 cites·47 claims
- 0793US10214589B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2017·Granted Feb 26, 2019·9 cites·18 claims
- 0890US2025066497A1Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2024·Application pending·0 cites
- 0988US2024182595A1Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2023·Application pending·0 cites
- 1053US11352358B2FXR agonistXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 7, 2022·0 cites·6 claims
- 1146US2010093611A1Compounds and methods for treating or preventing autoimmune diseasesHORRIGAN STEPHEN K·Filed 2008·Application pending·0 cites
- 1240US11407757B2Heterocycle compounds as Tyro3, Axl and MerTK (TAM) family of receptor tyrosine kinase inhibitorsDEV CT BIOTECHNOLOGY·Filed 2018·Granted Aug 9, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Bo Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →